VEZF1 transcriptionally activates progestin and adipoQ receptor 4 (PAQR4) to accelerate HCC progression, while STUB1-mediated ubiquitination of VEZF1 leads to diminished transcriptional activity and attenuated liver cancer development [19]. Here, VEZF1 is linked to hepatocellular carcinoma.